Evotec SE (EVO) Cost of Revenue (2009 - 2025)
Evotec SE's (EVO) quarterly Cost of Revenue came in at $203474.8 in Q4 2025, up 8.75% year-over-year from $187111.1 in Q4 2024, and down 96.69% quarter-over-quarter from $6.1 million in Q3 2025.
Analysis
Evotec SE (EVO) Cost of Revenue (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Cost of Revenue across 9 years of filings, most recently posting $203474.8 for Q4 2025.
- In Q4 2025, Cost of Revenue rose 8.75% year-over-year to $203474.8; the TTM figure through Dec 2025 stood at $12.6 million (changed 0.01% YoY), while the FY2025 annual figure was $761718.7, down 99.9% from the prior year.
- Cost of Revenue came in at $203474.8 for Q4 2025 at Evotec SE, down from $6.1 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $476.3 million in Q4 2023 to a low of $123525.8 in Q1 2021.
- Average Cost of Revenue over 5 years is $90.9 million, with a median of $3.8 million recorded in 2024.
- Year-over-year, Cost of Revenue soared 117167.89% in 2021 and sank 99.96% in 2024.
- Over 5 years, Cost of Revenue stood at $379.2 million in 2021, then grew by 12.77% to $427.6 million in 2022, then rose by 11.39% to $476.3 million in 2023, then slumped by 99.96% to $187111.1 in 2024, then climbed by 8.75% to $203474.8 in 2025.
- Per Business Quant data, the three most recent Cost of Revenue figures were $203474.8 in Q4 2025, $6.1 million in Q3 2025, and $4.6 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 2.93 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 505.69 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 552.01 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 1.58 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 539.00 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 1.72 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 6.81 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 1.18 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 203,474.81 |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Dec 31, 2024 | 187,111.05 |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 4.81 Mn |
| Mar 31, 2024 | 3.77 Mn |
| Dec 31, 2023 | 476.35 Mn |
| Jun 30, 2023 | 174.58 Mn |
| Dec 31, 2022 | 427.64 Mn |
| Sep 30, 2022 | 337,771.90 |
| Jun 30, 2022 | 150.78 Mn |
| Mar 31, 2022 | 148,572.82 |
| Dec 31, 2021 | 379.22 Mn |
| Sep 30, 2021 | 331,379.74 |
| Jun 30, 2021 | 1.32 Mn |
| Mar 31, 2021 | 123,525.82 |
| Dec 31, 2020 | 323,378.81 |
| Sep 30, 2020 | 1.51 Mn |